Literature DB >> 33827852

The mobility gap: estimating mobility thresholds required to control SARS-CoV-2 in Canada.

Kevin A Brown1, Jean-Paul R Soucy2, Sarah A Buchan2, Shelby L Sturrock2, Isha Berry2, Nathan M Stall2, Peter Jüni2, Amir Ghasemi2, Nicholas Gibb2, Derek R MacFadden2, Nick Daneman1.   

Abstract

BACKGROUND: Nonpharmaceutical interventions remain the primary means of controlling severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) until vaccination coverage is sufficient to achieve herd immunity. We used anonymized smartphone mobility measures to quantify the mobility level needed to control SARS-CoV-2 (i.e., mobility threshold), and the difference relative to the observed mobility level (i.e., mobility gap).
METHODS: We conducted a time-series study of the weekly incidence of SARS-CoV-2 in Canada from Mar. 15, 2020, to Mar. 6, 2021. The outcome was weekly growth rate, defined as the ratio of cases in a given week versus the previous week. We evaluated the effects of average time spent outside the home in the previous 3 weeks using a log-normal regression model, accounting for province, week and mean temperature. We calculated the SARS-CoV-2 mobility threshold and gap.
RESULTS: Across the 51-week study period, a total of 888 751 people were infected with SARS-CoV-2. Each 10% increase in the mobility gap was associated with a 25% increase in the SARS-CoV-2 weekly case growth rate (ratio 1.25, 95% confidence interval 1.20-1.29). Compared to the prepandemic baseline mobility of 100%, the mobility threshold was highest in the summer (69%; interquartile range [IQR] 67%-70%), and dropped to 54% in winter 2021 (IQR 52%-55%); a mobility gap was present in Canada from July 2020 until the last week of December 2020.
INTERPRETATION: Mobility strongly and consistently predicts weekly case growth, and low levels of mobility are needed to control SARS-CoV-2 through spring 2021. Mobility measures from anonymized smartphone data can be used to guide provincial and regional loosening and tightening of physical distancing measures.
© 2021 CMA Joule Inc. or its licensors.

Entities:  

Year:  2021        PMID: 33827852     DOI: 10.1503/cmaj.210132

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  7 in total

1.  Identifying spatiotemporal patterns of COVID-19 transmissions and the drivers of the patterns in Toronto: a Bayesian hierarchical spatiotemporal modelling.

Authors:  Nushrat Nazia; Jane Law; Zahid Ahmad Butt
Journal:  Sci Rep       Date:  2022-06-07       Impact factor: 4.996

2.  Novel mobility index tracks COVID-19 transmission following stay-at-home orders.

Authors:  Peter Hyunwuk Her; Sahar Saeed; Khai Hoan Tram; Sahir R Bhatnagar
Journal:  Sci Rep       Date:  2022-05-10       Impact factor: 4.996

3.  Impact of the COVID-19 Pandemic on Diabetes Care for Adults With Type 2 Diabetes in Ontario, Canada.

Authors:  John S Moin; Natalie Troke; Lesley Plumptre; Geoffrey M Anderson
Journal:  Can J Diabetes       Date:  2022-05-02       Impact factor: 2.774

4.  COVID-19 Vaccination and Public Health Countermeasures on Variants of Concern in Canada: Evidence From a Spatial Hierarchical Cluster Analysis.

Authors:  Daniel A Adeyinka; Cory Neudorf; Cheryl A Camillo; Wendie N Marks; Nazeem Muhajarine
Journal:  JMIR Public Health Surveill       Date:  2022-05-31

5.  Short-term exposure to ambient air pollution and individual emergency department visits for COVID-19: a case-crossover study in Canada.

Authors:  Eric Lavigne; Niilo Ryti; Antonio Gasparrini; Francesco Sera; Scott Weichenthal; Hong Chen; Teresa To; Greg J Evans; Liu Sun; Aman Dheri; Lionnel Lemogo; Serge Olivier Kotchi; Dave Stieb
Journal:  Thorax       Date:  2022-03-31       Impact factor: 9.139

6.  Stringency of containment and closures on the growth of SARS-CoV-2 in Canada prior to accelerated vaccine roll-out.

Authors:  David M Vickers; Stefan Baral; Sharmistha Mishra; Jeffrey C Kwong; Maria Sundaram; Alan Katz; Andrew Calzavara; Mathieu Maheu-Giroux; David L Buckeridge; Tyler Williamson
Journal:  Int J Infect Dis       Date:  2022-02-23       Impact factor: 12.074

7.  On the role of financial support programs in mitigating the SARS-CoV-2 spread in Brazil.

Authors:  Vinicius V L Albani; Roseane A S Albani; Nara Bobko; Eduardo Massad; Jorge P Zubelli
Journal:  BMC Public Health       Date:  2022-09-20       Impact factor: 4.135

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.